Table of Contents Table of Contents
Previous Page  29 / 62 Next Page
Information
Show Menu
Previous Page 29 / 62 Next Page
Page Background

QUALITATIVE RESEARCH CONSULTANTS ASSOCIATION

29

Yale professor William Deresiewicz

writes about in his book,

Excellent Sheep

.

About 20% use mood-altering sub-

stances to manage feelings or to

“self-medicate.” SAMHSA’s 2013 survey

measures the use of illicit drugs at 21.5%

among young adults aged 18 to 25 versus

9.4% for all Americans over age 12.

Marijuana is the most popular and

fastest-growing drug. Because today’s

marijuana plants have been bred to con-

tain levels of THC (marijuana’s main

psychoactive ingredient) 10 times higher

than plants did 20 years ago, mental

health professionals are seeing a rash of

marijuana-induced anxiety and psycho-

ses. We might expect to see some push-

back from health providers as states

expand legalization of marijuana.

Stress, Challenges, and

the Medical Treatment Model

Perspectives on mental health trends

run hot—and in researching underlying

causes and implications, explanations

vary in scope and inflammatory tone.

For example, changes to diagnostic crite-

ria have some parents fearful their chil-

dren will no longer qualify for special

services, while some providers and their

patients worry that only pharmaceutical

solutions will be reimbursable. Here is

how I see it at the moment, but stay

open and I encourage you to draw your

own conclusions.

According to the well-respected

National Alliance of Mental Illness

(NAMI), the percentage of the U.S. pop-

ulation suffering from anxiety disorders

such as PTSD, obsessive-compulsive dis-

order, or specific phobias runs about

18% (or 42 million people last year). Just

under 7% of adults (or 16 million) live

with a major depression, while 6.1 mil-

lion live with bipolar disorder and 2.4

million with schizophrenia.

Two significant challenges in the

industry are:

• Delivering treatment to those in

need.

The majority of those who suffer

do not get treatment. NAMI reports that

close to 60% of affected adults and 50%

of affected children did not receive

mental health treatment in the previous

year. Federal requirements for parity of

coverage with medical and surgical ser-

vices in new healthcare plans should

help increase access to needed mental

health and substance abuse treatment.

• Differential diagnosing.

Diagnostic

manuals such as the DSM-V help clinicians

diagnose by clustering symptoms—not an

easy task when almost every mental health

issue includes anxiety as a symptom.

In a typical medical model, the physi-

cian attempts to promote healing and

cure ailments. For example, she might

set a broken limb or treat an infection

with antibiotics. The treatment model in

mental health is notably different. Here,

physicians and other clinicians use med-

ications and in-office therapies to

improve a patient’s quality of life—they

acknowledge their patients might always

be addicts or might always struggle with

recurring depression, but behavioral

and/or pharmaceutical therapies can

help them manage their symptoms and

lead fulfilled lives.

Indeed, most mental illnesses are not

cured

by pharmaceutical drugs, but the

illnesses can be managed and symptoms

treated. In fact, medical science doesn’t

truly know

how

or

why

many of these

drugs work. In a 2014 report on mental

health medicines under development,

PhRMA (a pharmaceutical advocacy

group) acknowledged that developing

effective treatments for mental disorders

“has been hindered by many factors,

including a limited understanding of

how current treatments work in the

brain.”

Still, exciting advances in neuroscience

research are shedding light on the brain’s

mechanisms for some kinds of depres-

sion, which ultimately may turn into

breakthrough pharmaceutical

approaches. In the meantime, new

understandings about our brain’s neuro-

plasticity coupled with Stephen Porges’

groundbreaking Polyvagal Theory (that

a key part of our central nervous system

serves different evolutionary stress

responses) is leading to alternative treat-

ments of anxiety, depression, trauma,

and autism. These non-pharmaceutical

therapies include yoga, mindfulness,

neurofeedback, and play therapies—

many of which are not yet covered by

health insurance plans.

20 Minute Psychiatric Visits

The relatively low cost and effective-

Yoga & meditation among alternative therapies